Charles Schwab’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $460K | Sell |
|
|||||
|
2025
Q2 | $371K | Buy |
|
|||||
|
2025
Q1 | $50.6K | Hold |
|
|||||
|
2024
Q4 | $82K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $287K | Sell |
|
|||||
|
2024
Q1 | $520K | Sell |
|
|||||
|
2023
Q4 | $458K | Sell |
|
|||||
|
2023
Q3 | $3.17M | Buy |
|
|||||
|
2023
Q2 | $4.61M | Buy |
|
|||||
|
2023
Q1 | $3.32M | Sell |
|
|||||
|
2022
Q4 | $6.49M | Buy |
|
|||||
|
2022
Q3 | $6.34M | Buy |
|
|||||
|
2022
Q2 | $2.15M | Buy |
|
|||||
|
2022
Q1 | $2.29M | Buy |
|
|||||
|
2021
Q4 | $1.88M | Buy |
|
|||||
|
2021
Q3 | $2.29M | Buy |
|
|||||
|
2021
Q2 | $1.89M | Buy |
|
|||||
|
2021
Q1 | $398K | Sell |
|
|||||
|
2020
Q4 | $133K | Hold |
|
|||||
|
2020
Q3 | $53K | Hold |
|
|||||
|
2020
Q2 | $34K | Sell |
|
|||||
|
2020
Q1 | $89K | Hold |
|
|||||
|
2019
Q4 | $161K | Hold |
|
|||||
|
2019
Q3 | $92K | Sell |
|
|||||
|
2019
Q2 | $453K | Buy |
|
|||||
|
2019
Q1 | $1.04M | Sell |
|
|||||
|
2018
Q4 | $1.48M | Buy |
|
|||||
|
2018
Q3 | $1.95M | Buy |
|
|||||
|
2018
Q2 | $2.44M | Sell |
|
|||||
|
2018
Q1 | $2.2M | Buy |
|
|||||
|
2017
Q4 | $3M | Buy |
|
|||||
|
2017
Q3 | $2.39M | Buy |
|
|||||
|
2017
Q2 | $1.68M | Buy |
|
|||||
|
2017
Q1 | $1.31M | Buy |
|
|||||
|
2016
Q4 | $1.12M | Buy |
|
|||||
|
2016
Q3 | $629K | Buy |
|
|||||
|
2016
Q2 | $439K | Buy |
|
|||||
|
2016
Q1 | $320K | Buy |
|
|||||
|
2015
Q4 | $447K | Buy |
|